Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LVTX NYSE:QHC NASDAQ:RADX NYSE:SSY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLVTXLAVA Therapeutics$1.53$1.38$0.85▼$2.09$40.25M0.5143,952 shs221,142 shsQHCQuorum Health$0.30$0.37$0.22▼$2.49$10.01M2.29266,388 shsN/ARADXRadiopharm Theranostics$4.68-3.5%$4.66$3.50▼$50.82$36.85MN/A23,571 shs8,309 shsSSYSunLink Health Systems$1.02-5.6%$1.02$0.62▼$1.91$7.18M1.16144,276 shs321,666 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLVTXLAVA Therapeutics0.00%+7.75%+13.33%+22.40%-12.57%QHCQuorum Health0.00%0.00%0.00%0.00%0.00%RADXRadiopharm Theranostics0.00%-12.52%+11.43%+11.96%+467,999,900.00%SSYSunLink Health Systems0.00%-1.92%+3.24%+11.60%+23.64%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLVTXLAVA Therapeutics1.7074 of 5 stars3.05.00.00.01.50.00.0QHCQuorum HealthN/AN/AN/AN/AN/AN/AN/AN/ARADXRadiopharm TheranosticsN/AN/AN/AN/AN/AN/AN/AN/ASSYSunLink Health Systems0.9298 of 5 stars0.03.00.00.00.01.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLVTXLAVA Therapeutics 2.00Hold$2.6975.49% UpsideQHCQuorum Health 0.00N/AN/AN/ARADXRadiopharm Theranostics 3.67Strong Buy$15.00220.51% UpsideSSYSunLink Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest QHC, SSY, RADX, and LVTX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/5/2025LVTXLAVA TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$1.50 ➝ $1.248/5/2025LVTXLAVA TherapeuticsJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$3.00 ➝ $1.507/21/2025RADXRadiopharm TheranosticsBrookline Capital ManagementSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$18.005/15/2025LVTXLAVA TherapeuticsJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform5/12/2025RADXRadiopharm TheranosticsThinkEquitySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLVTXLAVA Therapeutics$11.98M3.36N/AN/A$1.06 per share1.44QHCQuorum Health$1.88B0.01$0.66 per share0.46($2.38) per share-0.13RADXRadiopharm TheranosticsN/AN/AN/AN/AN/AN/ASSYSunLink Health Systems$31.09M0.23N/AN/A$2.00 per share0.51Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLVTXLAVA Therapeutics-$25.11M-$1.04N/AN/AN/AN/A-86.38%-34.12%8/19/2025 (Estimated)QHCQuorum Health-$200.25MN/AN/A∞N/A-8.65%N/A-4.00%N/ARADXRadiopharm TheranosticsN/AN/A0.00∞N/AN/AN/AN/AN/ASSYSunLink Health Systems-$1.53M$0.247.29∞N/A3.20%-20.94%-16.09%N/ALatest QHC, SSY, RADX, and LVTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/19/2025Q2 2025LVTXLAVA Therapeutics-$0.28N/AN/AN/AN/AN/A5/14/2025Q1 2025LVTXLAVA Therapeutics-$0.37-$0.13+$0.24-$0.13N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLVTXLAVA TherapeuticsN/AN/AN/AN/AN/AQHCQuorum HealthN/AN/AN/AN/AN/ARADXRadiopharm TheranosticsN/AN/AN/AN/AN/ASSYSunLink Health SystemsN/AN/AN/AN/AN/ALatest QHC, SSY, RADX, and LVTX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/21/2025SSYSunLink Health Systemsspecial$0.107/29/20257/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLVTXLAVA TherapeuticsN/A6.736.73QHCQuorum HealthN/A1.211.10RADXRadiopharm TheranosticsN/AN/AN/ASSYSunLink Health SystemsN/A4.063.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLVTXLAVA TherapeuticsN/AQHCQuorum Health58.36%RADXRadiopharm TheranosticsN/ASSYSunLink Health Systems23.67%Insider OwnershipCompanyInsider OwnershipLVTXLAVA Therapeutics9.50%QHCQuorum Health6.10%RADXRadiopharm TheranosticsN/ASSYSunLink Health Systems27.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLVTXLAVA Therapeutics6026.31 million23.81 millionOptionableQHCQuorum Health11,60032.92 millionN/AOptionableRADXRadiopharm TheranosticsN/A7.88 millionN/AN/ASSYSunLink Health Systems1,3767.04 million5.08 millionNot OptionableQHC, SSY, RADX, and LVTX HeadlinesRecent News About These CompaniesRegional Health Properties, Inc. and SunLink Health Systems, Inc. ...August 4, 2025 | gurufocus.comRegional Health Properties, Inc. and SunLink Health Systems, Inc. Announce Receipt of Shareholder Approvals for MergerAugust 4, 2025 | businesswire.comRegional Health Properties, Inc. and SunLink Health Systems, Inc. ...August 4, 2025 | gurufocus.comSunLink Health Systems, Inc. Adjourns Special Meeting Until August 4, 2025 and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger With Regional Health Properties, Inc. by August 3, 2025 at 11:59 PM EDTJuly 29, 2025 | businesswire.comA Closer Look at SunLink’s (SSY) Special DividendJuly 26, 2025 | msn.comSunlink Health Systems Receives NYSE American Deficiency NoticeJuly 26, 2025 | theglobeandmail.comSunLink Health Systems updates on planned special cash dividendJuly 24, 2025 | msn.comSunLink Health Systems, Inc. provides an Update on Proxy Voting for the Proposed Merger with Regional Health Properties, Inc. and Urges Stockholders of Record as of June 20, 2025 to Vote FOR the Proposed Merger by July 28, 2025 at 11:59 PM EDTJuly 24, 2025 | businesswire.comSunLink Health Systems, Inc. Provides Update on Special Cash Dividend Scheduled to Be Paid Prior to SunLink's Proposed Merger with Regional Health Properties, Inc.July 24, 2025 | businesswire.comSunLink Health Systems, Inc Declares Special Cash Dividend Prior to with the Proposed Merger with Regional Health Properties, Inc.July 21, 2025 | businesswire.comSunLink Health Systems Declares 10c Special DivJuly 19, 2025 | marketwatch.comSunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing ... - MorningstarJuly 8, 2025 | morningstar.comMSunLink Health Systems Announces That It Received a NYSE American LLC Notice Indicating That SunLink Has Fallen Below Certain NYSE American Continued Listing StandardsJuly 7, 2025 | businesswire.comSunlink Health Systems Extends Merger Agreement DeadlineJune 23, 2025 | tipranks.comSunLink Health Systems, Inc. Announces Fiscal 2025 Third Quarter ResultsMay 13, 2025 | businesswire.comREGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS REVISE ALL-STOCK MERGER TRANSACTIONApril 15, 2025 | markets.businessinsider.comSunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter ResultsFebruary 12, 2025 | businesswire.comRegional Health Properties to merge with Sunlink Health SystemsJanuary 8, 2025 | mcknightsseniorliving.comMRegional Health, SunLink Health to merge in all-stock transactionJanuary 7, 2025 | markets.businessinsider.comSunLink Health Systems Inc (SSY) Stock Trading RecapJanuary 7, 2025 | bovnews.comBNew MarketBeat Followers Over TimeMedia Sentiment Over TimeQHC, SSY, RADX, and LVTX Company DescriptionsLAVA Therapeutics NASDAQ:LVTX$1.53 0.00 (0.00%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.54 +0.00 (+0.33%) As of 08/8/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.Quorum Health NYSE:QHCQuorum Health Corporation, together with its subsidiaries, provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, diagnostic, obstetric, psychiatric, and rehabilitation services. Quorum Health Corporation offers its healthcare services through its hospitals and affiliated facilities, including urgent care centers, diagnostic and imaging centers, physician clinics, and surgery centers. The company, through its subsidiary, Quorum Health Resources, LLC, provides hospital management advisory, healthcare consulting, and group purchasing services to non-affiliated hospitals, as well as Web-based applications and software tools; and various education programs for healthcare leaders, professionals, and other medical staff. As of December 31, 2018, it owned or leased 27 hospitals with approximately 2,604 licensed beds. The company was incorporated in 2015 and is headquartered in Brentwood, Tennessee.Radiopharm Theranostics NASDAQ:RADX$4.68 -0.17 (-3.51%) As of 08/8/2025 03:59 PM EasternRadiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.SunLink Health Systems NYSE:SSY$1.02 -0.06 (-5.56%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$1.05 +0.03 (+2.84%) As of 08/8/2025 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
